Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “AstraZeneca”
- Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor AgonistActive Not Recruiting
Sponsor: AstraZeneca
Endocrinology · Diabetes, Type II · Obesity
United States
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
COPD · Chronic Obstructive Pulmonary Disease
United States
- Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLCActive Not Recruiting
Sponsor: Canadian Cancer Trials Group
Lung Cancer Metastatic
Australia, Canada
Sponsor: AstraZeneca
Healthy Participants
United States
Sponsor: AstraZeneca
Primary Aldosteronism · Hyperaldosteronism
United States
- D9319C00001- 1L OC Mono Global RCTActive Not Recruiting
Sponsor: AstraZeneca
Ovarian Cancer
Chile, China, Colombia, India, Peru +5 more
Sponsor: University of Pennsylvania
Diabetic Nephropathies · Kidney Diseases · Renal Insufficiency, Chronic · Diabetes Mellitus, Type 2
United States
Sponsor: AstraZeneca
Haematologic Neoplasms
United States, Australia, Japan, South Korea, Spain +2 more
Sponsor: AstraZeneca
Asthma
United States, Argentina, Belgium, Chile, China +18 more
Sponsor: AstraZeneca
Hormone Receptor Positive Breast Cancer
United States, Argentina, Brazil, Canada, China +15 more
Sponsor: Daiichi Sankyo
Breast Cancer
United States, Australia, Belgium, Brazil, Czechia +10 more
- Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cancer (DOLPHIN)Active Not Recruiting
Sponsor: Michael Hopp
Small Cell Lung Cancer Limited Stage
Germany
Sponsor: AstraZeneca
Mild Asthma
United States
- Acalabrutinib, Umbralisib, and Ublituximab (AU2) In Relapsed and Untreated CLLActive Not Recruiting
Sponsor: Jennifer R. Brown, MD, PhD
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma · Relapsed Chronic Lymphocytic Leukemia · Refractory Chronic Lymphocytic Leukemia
United States
Sponsor: Gordon Mills, MD, PhD
Anatomic Stage IV Breast Cancer AJCC v8 · Metastatic Triple-Negative Breast Carcinoma
United States
- Saphnelo Use in Females of Child-bearing PotentialNot Yet Recruiting
Sponsor: AstraZeneca
Systemic Lupus Erythematosus
Sponsor: AstraZeneca
Mucociliary Clearance
United States, United Kingdom
- Molecular Residual Disease Interception in Locoregionally-Advanced High Risk HPV+ and HPV- HNSCCRecruiting
Sponsor: University Health Network, Toronto
Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
Canada
Sponsor: AstraZeneca
Advanced Metastatic Breast Cancer
United States
Sponsor: AstraZeneca
Gastric Cancer · Gastro-esophageal Junction Cancer · Pancreatic Ductal Adenocarcinoma · Esophageal Adenocarcinoma
United States, China, France, Japan, Netherlands +3 more
Sponsor: Memorial Sloan Kettering Cancer Center
Brain Cancer · Glioblastoma · Metastatic Cancer · Leptomeningeal Metastasis
United States
- Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell CarcinomaActive Not Recruiting
Sponsor: UNC Lineberger Comprehensive Cancer Center
Carcinoma, Squamous Cell · Oral Cancer · Oropharynx Cancer · Larynx Cancer
United States
- Olaparib + Sapacitabine in BRCA Mutant Breast CancerActive Not Recruiting
Sponsor: Dana-Farber Cancer Institute
Breast Cancer
United States
Sponsor: AstraZeneca
Metastatic Prostate Cancer
United States, Australia, Spain
Sponsor: Memorial Sloan Kettering Cancer Center
Non-Small Cell Lung Cancer · Non-small Cell Lung Cancer Stage II · Non-Small Cell Lung Cancer Stage IIIA · Non-Small Cell Lung Cancer Stage IIIB
United States, Canada